Barclays analyst Dan Levy raised the firm’s price target on Visteon to $135 from $125 and keeps an Underweight rating on the shares. The company reported "robust" revenue growth in Q4 but its margins remain mixed, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VC: